<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2549">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04395144</url>
  </required_header>
  <id_info>
    <org_study_id>2021-01</org_study_id>
    <nct_id>NCT04395144</nct_id>
  </id_info>
  <brief_title>COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss</brief_title>
  <acronym>COVAYDE</acronym>
  <official_title>Randomized-controlled Trial of HFNC Alone vs HFNC and Awake Self-proning for Treatment of Severe COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital de Verdun</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital de Verdun</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prone positioning is an established intervention in mechanically ventilated acute respiratory
      distress syndrome (ARDS) patients, with demonstrated reductions in mortality.

      Preliminary data suggest that awake proning in patients with COVID-19 treated with high-flow
      nasal oxygenation (HFNO) improves gas exchanges, and might be associated with a reduced need
      of mechanical ventilation, and reduced mortality. Further investigation in a formal
      randomized-controlled trial is need.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Therapeutic failure, defined as a combined outcome of rate of intubation or death</measure>
    <time_frame>Up to 28 days after randomization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubation rate</measure>
    <time_frame>Up to 28 days after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Up to 28 days after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days spent on mechanical ventilation</measure>
    <time_frame>Until discharge, up to 24 weeks after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days spent in the ICU</measure>
    <time_frame>Until discharge, up to 24 weeks after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay (in days)</measure>
    <time_frame>From admission to discharge, up to 24 weeks after randomization</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Time in prone position</measure>
    <time_frame>Up to 28 days post randomization</time_frame>
    <description>Total time spent in prone position, as recorded by nursing or respiratory therapists</description>
  </other_outcome>
  <other_outcome>
    <measure>Oxygenation (SpO2/FiO2 ratio)</measure>
    <time_frame>Until HFNC weaning, or up to 14 days after randomization, whichever is first</time_frame>
    <description>Daily evolution of oxygenation</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">346</enrollment>
  <condition>Coronavirus Infection</condition>
  <condition>COVID</condition>
  <condition>Severe Acute Respiratory Syndrome</condition>
  <condition>Respiratory Failure</condition>
  <condition>Respiratory Insufficiency</condition>
  <condition>Respiratory Distress Syndrome</condition>
  <condition>ARDS</condition>
  <condition>Lung Diseases</condition>
  <arm_group>
    <arm_group_label>Awake prone positioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prone positioning of patients on nasal high-flow oxygen therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard decubitus positioning of patients on nasal high-flow oxygen therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Awake Prone Positioning</intervention_name>
    <description>Patients will receive instruction to remain in prone position as long and as often as possible, up to 16h/24h</description>
    <arm_group_label>Awake prone positioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <description>Patients will not receive any special instructions with regards to proning.</description>
    <arm_group_label>Standard care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COVID-19, either confirmed by SARS-CoV-2 assay, or clinically suspected, with results
             of the assay pending;

          -  Lung infiltrates documented on chest X-ray or chest CT-scan;

          -  Significant respiratory distress that requires treatment with HFNO.

        Exclusion Criteria:

          -  Unable to consent;

          -  Unable to prone;

          -  Indication for immediate endotracheal intubation and mechanical ventilation;

          -  Contraindication to prone positioning (severe obesity, abdominal wound, pregnancy,
             unstable pelvic/spinal lesions, vomiting, etc.);

          -  Comfort care or imminent expectation of death.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ivan Pavlov, MD</last_name>
    <phone>15143621000</phone>
    <phone_ext>63525</phone_ext>
    <email>ivan.pavlov.md@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital de Verdun</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H4G2A2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Pavlov, MD</last_name>
      <phone>5143621000</phone>
      <email>ivan.pavlov.md@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 15, 2020</study_first_submitted>
  <study_first_submitted_qc>May 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>August 9, 2020</last_update_submitted>
  <last_update_submitted_qc>August 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hôpital de Verdun</investigator_affiliation>
    <investigator_full_name>Ivan Pavlov</investigator_full_name>
    <investigator_title>Emergency physician</investigator_title>
  </responsible_party>
  <keyword>SARS-CoV-2</keyword>
  <keyword>SARS-CoV-2 infection</keyword>
  <keyword>COVID-19</keyword>
  <keyword>HFNC</keyword>
  <keyword>HFNO</keyword>
  <keyword>Proning</keyword>
  <keyword>Prone position</keyword>
  <keyword>High-flow nasal cannula</keyword>
  <keyword>High-flow nasal oxygenation</keyword>
  <keyword>Acute Respiratory Distress Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

